Barclays rated Intuitive Surgical, GE Healthcare, and Abbott Laboratories as Overweight on October 7, 2026.

The entities involved

• Intuitive Surgical →

  American corporation

  • Investors are weighing established medical giants like Intuitive Surgical and Abbott Laboratories against high-growth specialists such as Lingo.Mon 21:12
  • Companies like Teradyne, UiPath, and Intuitive Surgical are offering investment opportunities in physical AI.Sat 16:21
• GE Healthcare →

  company

  • GE HealthCare announced on August 21, 2025, that it was using LinkedIn for company news, and Jennifer Fox serves as the media contact.Sun 16:58
• Abbott Laboratories →

  American global health care and medical device products company

  • Corporate restructuring news includes the transformation of CORDIS from a division of Cardinal Health, the acquisitions of Guidant by Boston Scientific and Abbott Laboratories, and appointments involving Cirtec Medical.Mon 19:12
  • Benchmark reduced its price target and set a buy rating for Abbott Laboratories, while Royal Bank of Canada issued an outperform rating on July 29, 2026.Fri 08:13

Related events

• Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.Jul 29
• RBC and Bank of America issued research reports on Intuitive Surgical.Sep 22